CMMB
Chemomab Therapeutics
CMMB
CMMB
16 hedge funds and large institutions have $7.53M invested in Chemomab Therapeutics in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$26K | |
| 2 | +$18.1K | |
| 3 | +$17.6K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$11.8K |
| 5 |
GI
GAMMA Investing
Foster City,
California
|
+$9.23K |
Top Sellers
| 1 | -$539K | |
| 2 | -$119K | |
| 3 | -$62.7K | |
| 4 |
HF
HRT Financial
New York
|
-$21K |
| 5 |
Millennium Management
New York
|
-$16.6K |